After graduating from BYU, Stephen has charted an unusual path in the biotech industry. He’ll talk about this journey, career options in the biopharma space, and what he’s up to now at Curebase.
Stephen is an Associate Director of Business Development at Curebase, a fast-growing startup that’s running the next generation of clinical trials. Earlier this year, Curebase raised a $40M Series B with VC investors and industry partners, including Gilead Sciences. They have supported more than 60 studies to date, including multiple successful FDA submission studies.